IL6 and clostridium difficile infection: There were statistically significant differences (p < 0.05) between the recurrent and non-recurrent groups in terms of age, the presence of comorbidities, history of antibiotic exposure, mode of CDI acquisition, colonoscopy examination, treatment plan selection, levels of interleukin (IL)-6 and creatine kinase (CK), and body mass index.